当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Brynn Riveland, Emily Potter, Melinda Gaddy, Gunther Wehrman
Background: This study aims to determine if longer antimicrobial treatment duration (>7 days) for UTI in male outpatient veterans is associated with a difference in early or late recurrence rates compared to a shorter antimicrobial treatment duration (≤ 7 days).
Methods: This study included adult, male patients of VA Eastern Kansas Health Care System with an index UTI episode between August 1st, 2020 and August 1st, 2021. If UTI recurred, infection was classified as either early (≤ 30 days) or late (>30 days) recurrence. Logistic regression models were used to evaluate the duration of antimicrobial treatment on recurrence.
Results: The effects of duration of treatment on early recurrence (P:0.5041, OR:0.660, CI:0.194-2.237) and duration of treatment on late recurrence (P:0.5024, OR:0.703, CI:0.251-1.969) both showed statistical insignificance.
Conclusion: There was no difference between long and short duration on both early and late recurrence, therefore it may not be necessary for male patients to be treated for the recommended longer duration of treatment.